Literature DB >> 8095436

Monocyte-macrophage lineage of giant cell tumor of bone. Establishment of a multinucleated cell line.

T S Huang1, A D Green, C W Beattie, T K Das Gupta.   

Abstract

METHOD: A new neoplastic cell line, UISO-GCT-1, was established from a giant cell tumor of the right tibia in an 18-year-old man. Immunohistochemical, cytogenetic, ultrastructural, and growth studies were performed.
RESULTS: Multinucleated giant cells (> 4-6 nuclei/cell) persisted in a culture relatively late in passage (passage 17), which is unique in cell lines of giant cell tumor of bone. Mononuclear and multinucleated cells in monolayer culture expressed vimentin and tartrate-resistant acid phosphatase and reacted with monoclonal antibodies to CD13 and CD68, suggesting a monocytic-macrophage origin of these cells. Mononuclear and multinuclear cells also selectively expressed high molecular weight cell membrane antigens specifically associated with soft tissue sarcomas and osteosarcomas. Karyotypically, UISO-GCT-1 cells were hypodiploid, hypotetraploid, and multiploid, with more than 200 chromosomes per mitosis present in some cells. Other chromosomal aberrations observed included ring chromosomes, double minutes, translocations, multiple fragments, and multiradials.
CONCLUSION: Collectively, observations of this study suggest that karyotypically abnormal giant cell tumors of bone arise from a monocyte-macrophage lineage and subsequently express an antigenic profile similar to malignant mesenchymal tumors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095436     DOI: 10.1002/1097-0142(19930301)71:5<1751::aid-cncr2820710509>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Histogenetic characterization of giant cell tumor of bone.

Authors:  Manuela Salerno; Sofia Avnet; Marco Alberghini; Armando Giunti; Nicola Baldini
Journal:  Clin Orthop Relat Res       Date:  2008-06-10       Impact factor: 4.176

2.  Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone.

Authors:  V H Rao; R K Singh; J A Bridge; J R Neff; G B Schaefer; D C Delimont; C M Dunn; W G Sanger; B A Buehler; R Sawaya; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

3.  Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone.

Authors:  V H Rao; J A Bridge; J R Neff; G B Schaefer; B A Buehler; J K Vishwanatha; R E Pollock; G L Nicolson; M Yamamoto; Z L Gokaslam
Journal:  Clin Exp Metastasis       Date:  1995-11       Impact factor: 5.150

4.  Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB.

Authors:  Teresa Morgan; Gerald J Atkins; Melanie K Trivett; Sandra A Johnson; Maya Kansara; Stephen L Schlicht; John L Slavin; Paul Simmons; Ian Dickinson; Gerald Powell; Peter F M Choong; Andrew J Holloway; David M Thomas
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

5.  Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration.

Authors:  M H Zheng; Y Fan; S J Wysocki; A T Lau; T Robertson; M Beilharz; D J Wood; J M Papadimitriou
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

6.  Biological characteristics of a novel giant cell tumor cell line derived from spine.

Authors:  Zhenhua Zhou; Yan Li; Leqin Xu; Xudong Wang; Su Chen; Cheng Yang; Jianru Xiao
Journal:  Tumour Biol       Date:  2016-01-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.